Molecular scanning for mutations in the beta 3-adrenergic receptor gene in Nauruans with obesity and noninsulin-dependent diabetes mellitus.

We recently identified a mutation in the human beta 3-adrenergic receptor (beta 3AR) gene (codon 64 TGGTrp -> CGGArg; TRP64ARG) that associates with features of the insulin resistance syndrome and an earlier onset of noninsulin-dependent diabetes mellitus (NIDDM). We scanned the beta 3AR gene for mutations by single stranded conformational polymorphism analysis in 20 Nauruans with obesity and NIDDM. No mutations were identified. Sixty-five Nauruan subjects were genotyped for the TRP64ARG beta 3AR. All subjects were homozygous for the normal allele. We genotyped Samoans and Asians for the TRP64ARG beta 3AR. Seven of 52 Samoans were heterozygous for the mutant arginine allele (allele frequency, 0.07). Of these, 5 were diabetic and 2 were nondiabetic (by Fisher's exact test, P = 0.4). There were trends toward increased body mass indices, waist to hip ratios, and 2-h insulin levels during oral glucose tolerance tests in Samoans with the mutation; however, the limited number of subjects available for study precluded rigorous statistical analysis. The TRP64ARG beta 3AR was also detected in Chinese, Chinese Americans, and subjects from the Indian subcontinent. In conclusion, the TRP64ARG beta 3AR mutation or any other mutation in the beta 3AR gene is not a major contributor to genetic susceptibility to NIDDM and obesity likely in Nauruans.

[1]  Barbara L. Smith,et al.  Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. , 1996, The New England journal of medicine.

[2]  K. Clément,et al.  Genetic Variation in the β3-Adrenergic Receptor and an Increased Capacity to Gain Weight in Patients with Morbid Obesity , 1995 .

[3]  C. Bogardus,et al.  Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. , 1995, The New England journal of medicine.

[4]  L. Groop,et al.  Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. , 1995, The New England journal of medicine.

[5]  P. Zimmet,et al.  Increasing Prevalence of NIDDM in the Pacific Island Population of Western Samoa Over a 13-Year Period , 1994, Diabetes Care.

[6]  P. Zimmet,et al.  Association of body mass index and waist-hip circumference ratio with cardiovascular disease risk factors in Micronesian Nauruans. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[7]  A. Strosberg,et al.  The promoter and intron/exon structure of the human and mouse beta 3-adrenergic-receptor genes. , 1993, European journal of biochemistry.

[8]  J. Beckmann,et al.  Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. , 1993, The New England journal of medicine.

[9]  D. Accili,et al.  Mutations in the insulin receptor gene. , 1992, Endocrine reviews.

[10]  M. Stoffel,et al.  Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[11]  J. Venter,et al.  An adipose tissue-specific beta-adrenergic receptor. Molecular cloning and down-regulation in obesity. , 1991, The Journal of biological chemistry.

[12]  P. Zimmet,et al.  Decline in incidence of epidemic glucose intolerance in Nauruans: implications for the "thrifty genotype". , 1991, American journal of epidemiology.

[13]  D. Steiner,et al.  Lessons Learned From Molecular Biology of Insulin-Gene Mutations , 1990, Diabetes Care.

[14]  A. Strosberg,et al.  Molecular characterization of the human beta 3-adrenergic receptor. , 1989, Science.

[15]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[16]  D. Slone,et al.  Critical Variables in the Radioimmunoassay of Serum Insulin Using the Double Antibody Technic , 1965, Diabetes.